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Abstract
Staphylococcus aureus sequence type (ST)398, which is commonly found as a colonization strain in pig farming, is emerging more fre-
quently as the cause of human infections. In this study, we analysed ST398 of porcine and human origin at the genetic, protein and
immunogenic levels. Although genetic analysis of the genes encoding the major virulence factors revealed the presence of the same
genes in all strains studied, the results demonstrated spa type crossing alterations in adhesion abilities in addition to a strongly enhanced
lysis activity directly linked to impaired clearance attributable to polymorphonuclear leukocytes (PMNs). This change in virulence pat-
tern indicates high heterogenicity in the ST398 pool that is not based on a different genetic make-up, but probably on variations in the
genetic regulation systems. These modiﬁcations, which are tightly connected to pathogenicity, cannot be detected by conventional diag-
nostic methods.
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Introduction
In recent years, companion and food-producing animals have
attracted attention as a reservoir of methicillin-resistant
Staphylococcus aureus (MRSA). These animals act as carriers
for different identiﬁed MRSA strains [1–3], but one of the
identiﬁed clonal lineages, sequence type (ST)398, is consid-
ered to exhibit a high pathogenic potential because of its
observed frequency in livestock and its special genetic abili-
ties [4]. In recent years, there have been more and more
studies of identiﬁed ST398 strains from all over the world
[5] as a livestock colonization strain, but there have also
been continuously increasing and alarming reports of human
infections [6–8]. There are case reports that include endo-
carditis [9], ventilator-associated pneumonia [10], and wound
infections [11]. It seems that MRSA ST398 is not only a
widespread livestock colonization strain, but also has the
ability to cross species barriers and to colonize and infect
humans. Previous studies have shown the ﬁrst indications of
a process of adaptation to humans by horizontal acquisition
of genetic material [12–14].
So far, most of the ST398 characterization data have been
generated by genetic analysis. This is certainly a powerful
tool for classifying the different S. aureus strains and for iden-
tifying antibiotic resistance proﬁles and central virulence fac-
tors, but it yields no information on protein expression or
the actual interaction with the human immune system. In this
study, we combined genetic analysis of ST398 strains from
different sources (pig/human) with protein biochemistry and
in vitro assays including components of the human immune
system. We show that, despite an apparently similar genetic
background, there are signiﬁcant differences between ST398
of porcine and human origin, based on variations in the exo-
protein pattern and cell-based abilities.
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Materials and Methods
Bacteria, growth analysis, and supernatant collection
All isolates were obtained from the Robert Koch Institute
(Wernigerode, Germany). The strains were selected on the
basis of the available information on the host and the clinical
appearance. Thus, two different strains each of colonizers
from pigs, colonizers from humans, and isolates from human
disease were included.
For collection of S. aureus supernatant (SaS), bacteria were
cultured in IMDM and pelleted by centrifugation, and the
cell-free supernatant was passed through a 0.2-lm-pore ﬁlter
(Whatman, Springﬁeld Mill, UK; Lot 8483799) to remove
bacterial residues. In order to avoid strong dilution effects in
the cell samples in some experimental settings, the ﬂuid vol-
ume of each overnight SaS sample was reduced by using a
Pierce 9-kDa Protein Concentrator (Pierce, Waltham, MA,
USA; Lot 137628B).
Spa and sequence typing
Spa and multilocus sequence typing (Table 1) were per-
formed by the Robert Koch Institute. The ST result was
conﬁrmed by microarray strain analysis (ST398). The genetic
background of each ST was checked with a previously
described diagnostic microarray system [15] by the Institute
of Medical Microbiology and Hygiene, Technical University,
Dresden, Germany. The results of SSCmec typing were con-
ﬁrmed by Etest (bioMe´rieux, Nuertingen, Germany).
Cell aggregation studies and ﬁbrinogen-binding assay
The adhesive abilities of bacterial cells from overnight culture
were measured by size determination after Coulter counter
(Beckmann Coulter, Brea, CA, USA) analysis. The mean
value of the particle size of each strain was calculated with
Multisizer3 software (Beckmann Coulter).
The bacteria from overnight culture (stationary phase)
were washed twice and incubated with human ﬁbrinogen
(1 mg/mL; Sigma-Aldrich, St Louis, MO, USA) for 10 min at
37C. The bacteria were then washed again and stained with
an anti-human ﬁbrinogen antibody (Agrisera, Vaennaes,
Sweden; Lot 0911) and analysed by ﬂuorescence-activated
cell sorting as described previously [16].
Isolation of human polymorphonuclear leukocytes (PMNs)
from whole blood and ﬂow cytometry analysis
Blood samples were collected from healthy donors between
21 and 59 years of age. The coagulation cascade was inhib-
ited by the addition of heparin (10 IU/mL; Ratiopharm, Ulm,
Germany). The Ethics Committee of the A¨rztekammer
Nordrhein accepted the study plan and the information leaf-
let for the participants. Written informed consent was
obtained from each study participant. A combination of dex-
tran (2%) sedimentation and subsequent Percoll centrifuga-
tion (66% and 76% Percoll gradients) was used for isolation
of PMNs from heparinized blood. The staining procedure,
cell ﬁxation and ﬂow cytometric analysis were performed as
described previously [16].
Killing of ST398 by isolated PMNs
The harvested and washed bacteria were diluted in NaCl
(0.9%) and co-cultured with isolated PMNs (2.5 · 106/mL) in
IMDM/5% homologous serum at a ratio of 5 : 1. To measure
the impact of the exoproteins, the PMNs were pre-incubated
for 15 min (37C) with and without 25· concentrated SaS
(1 : 100). Initially and after 2 h of rotation, the suspension of
PMNs and bacteria was plated in serial dilutions (10)2 to
10)4) onto HHD. The analysis was performed as described
previously [16].
Lysis of PMNs and erythrocytes by ST398 SaS
For the lysis test, isolated PMNs (2.5 · 106/mL) were resus-
pended in SaS/IMDM/5% homologous heat-inactivated serum
and incubated for 10 min (37C). The lysis reaction was
stopped with ice-cold NaCl (0.9%), and the proportion of
dead cells was immediately determined by ﬂow cytometry
analysis with propidium iodide staining (Becton Dickinson,
San Jose, CA, USA; Lot 38974000).
For haemolysis induction, SaS from 6-h cultures was used.
Heparinized whole blood was incubated with SaS (10%) at
37C in 5% CO2 for 6 h and centrifuged, and the plasma
was collected. The free haemoglobin as a classical factor for
haemolysis was measured as described previously [17].
a-Haemolysin detection in ST398 SaS
Nunc Maxisorp immunoplates (Nunc, Roskilde, Denmark)
were incubated overnight (4C). After washing (phosphate-
buffered saline, 0.05% Tween) and a blocking step (phosphate-
buffered saline/1% fetal bovine serum) for 1 h, a sheep anti-a-
haemolysin antibody (Abcam, Cambridge, MA, USA;
Lot 870471) directly conjugated with horseradish peroxidase
TABLE 1. Spa type, mecA gene, and origin of ST398 isolates
Spa type mecA Origin Disease pattern
ST398a t011 + Pig Nasal colonization
ST398b t011 + Human Nasal colonization
ST398c t034 + Pig Nasal colonization
ST398d t034 ) Human Nasal colonization
ST398e t034 + Human Wound infection
ST398f t034 + Human Abscess
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was added and incubated for another 2 h at room tempera-
ture. After three washing steps, horseradish peroxidase was
visualized with tetramethylbenzidine substrate (Sigma-Aldrich).
Statistics
Data are presented as mean values and standard deviations
for descriptive statistics, if not speciﬁed otherwise
(SPSS 17.0; IBM SPSS Statistics, Armonk, NY, USA). Normal
distribution was checked visually from distributions and with
the Shapiro–Wilk W-test. One-way and two-way repeated
measures ANOVA was used, and pairwise comparisons were
performed with an LSD test. As comparisons are considered
to be exploratory, no adjustment for multiplicity was per-
formed. p-Values <0.05 were considered to be signiﬁcant.
Results
Genetic analysis
Despite the different origins and disease patterns among the
ST398 isolates, no pivotal differences were detected. Aside
from the identical constitution of adhesion factors, all strains
were negative for the pvl gene and positive for the lukFHg,
lukSHg, hlgA, hla, hlb (untruncated), hld and aur genes (data
not shown).
Cell aggregation studies and ﬁbrinogen-binding assay
After a mean corpuscular volume (MCV) analysis performed
by Coulter counter, we identiﬁed two ST398 isolates (b and
f) of human origin with an altered cell size distribution pat-
tern. As compared with the other members of the ST398
group, they showed a more than 2.5-fold increase in the
MCV, representing the mean of the single cell volume
(Fig. 1a,b). Assuming a constant single-cell volume of
approximately 1 lm3, a mean accumulation of four cells per
unit can be concluded instead of one or two. This increase
in cell aggregates clearly indicates a variation in the expres-
sion or the adhesion ability of the bacterial cell wall compo-
nents.
The results were conﬁrmed by the ﬁbrinogen-binding
capacity of the selected strains. In contrast to their porcine
counterparts, ST398b and ST398f, which already exhibited
FIG. 1. The selected ST398 strains differ in their cell adhesion abilities. (a) Comparison of the mean corpuscular cell volumes (MCVs) of
selected ST398 strains from overnight culture. (b) Comparison of the distribution curves for cell volume (lm3)/cell number (%) for ST398c/
ST398f, and ST398b/ST398f. (c) Fibrinogen-binding capacity of ST398a, ST398b, ST398c and ST398f determined after incubation with human
ﬁbrinogen (1 mg/mL) and anti-ﬁbrinogen antibody staining. In order to avoid unspeciﬁc binding to, for example, protein G, the bacteria were
pre-incubated with goat IgG (100 mg/L; Jackson ImmunoResearch, West Grove, PA, USA; Lot 84538) to saturate possible antibody-catching mol-
ecules. Quantiﬁcation of ﬁbrinogen binding was performed by ﬂow cytometry analysis. The data are from six independent experiments. Error
bars indicate ± standard deviation. (n = 6; **p <0.01; ***p <0.001 as compared with porcine counterpart.)
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the highest aggregation ability, also represented those strains
with the highest amount of bound human ﬁbrinogen on the
cell surface (Fig. 1c).
Killing of ST398 by isolated PMNs
In this killing assay, the clearance rate of ST398 was deter-
mined from the mean of vital bacteria CFU per millilitre after
co-cultivation with isolated human PMNs. In order to
measure a possible exoprotein impact on this process, the
samples were pre-incubated with and without the strain-spe-
ciﬁc SaS (Fig. 2). Interestingly, in comparison with their
porcine counterparts without SaS impact, we observed
reduced killing with the strains of human origin. Additionally,
the experiments on exoprotein impact conﬁrmed the differ-
ences between the porcine and human ST398 isolates. Here,
especially after the pre-incubation with ST398f SaS, we found
a massive decrease in bacterial killing. This underlines the
special status of ST398f.
Lysis of erythrocytes and PMNs by ST398 SaS
In the haemolysis assay (Fig. 3a), we observed release of hae-
moglobin after the treatment with SaS from ST398b,
ST398d, and ST398f; ST398f affected erythrocyte lysis more
than three times more than the others. The effects of
ST398c and ST398e were at the level of the negative con-
trol.
The results of PMN lysis showed the same pattern. The
three ST398 strains causing haemolysis were also the three
strains with the highest impact on PMNs (Fig. 3b,c). How-
ever, in this case, only ST398b and ST398f were able to seri-
ously affect human PMNs. Surprisingly, at approximately 70%
(ST398b) and almost 100% (ST398f), the killing rate was very
high, and lysis was very effective, because the assay was
stopped and analysed after only 10 min of co-incubation.
Thus, the results conﬁrm the data analysed above. The high
impact of ST398f exoproteins on PMNs explains the strong
reduction in killing after co-incubation with the strain-speciﬁc
SaS.
a-Haemolysin in ST398 SaS
As haemolysins are well-known inducers of cell lysis, we per-
formed an a-haemolysin ELISA to determine the relative
amounts of such molecules in ST398 SaS. As expected from
the genetic results, we were able to detect this protein in
the overnight cultures of all ST398 strains. With optical den-
sity measurement, the strongest signals were observed with
the SaS from ST398b and ST398f (Fig. 3d). As compared with
the others, ST398b and ST398f had absorption increased by
more than 20-fold, indicating a strongly elevated level of this
protein in the SaS. This conﬁrms the special phenotype of
these two strains.
Discussion
As mentioned before, in the increasing number of reports
concerning ST398, there are more and more hints of an
evolutionary trend for increased pathogenicity of this S. aur-
eus strain for humans. One example of this is the ﬁrst
genetic evidence of Panton–Valentine leukocidin-positive
strains accompanied by genetic diversity between ST398 lin-
eages in China and Sweden [13,14,18] and non-typical car-
riage of enterotoxin genes found in Germany [19]. In
contrast, in this study, the microarray-based analysis of the
genetic background of the selected ST398 strains showed
FIG. 2. The killing rate of ST398 by polymorphonuclear leukocytes
(PMNs) depends on the exoprotein cocktail and also on cell-based
abilities. Bacteria were co-cultivated with isolated PMNs (2.5 · 106/
mL) in IMDM/5% homologous serum in a ratio of 5 : 1 for 2 h. After
culturing on HHD, the decline in vital bacterial cells was determined
from the change in log CFU/mL of the respective inoculum. To mea-
sure the impact of the exoproteins, the PMNs were pre-incubated
for 15 min (37C) with and without ST398 Staphylococcus aureus
supernatant (SaS). The data are from six independent experiments
including six different blood donors. Error bars indicate ± standard
deviation. (n = 6; *p <0.05; **p <0.01; without SaS impact, as com-
pared with porcine counterpart; with SaS impact, as compared with
killing without SaS impact.)
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only minor differences between the two tested spa types
and among the individual strains. As summarized in Fig. 1,
these variations are not found in the central virulence and
adhesion factors.
The ﬁrst spa type crossing variations in ST398 were
revealed after determination of the MCV of the bacterial col-
onies in the ﬂuid culture. A human ST398 colonization strain
(ST398b), characterized as spa type 011, and another strain
isolated from a human abscess (ST398f), a member of spa
type 034, can be distinguished from the other ST398 strains
by a more than 2.5-fold increase in colony size. This indi-
cates variation in cell-based adhesion abilities, and might be
caused by elevated expression of clumping factor, e.g. the
virulence factor clumping factor A. In ﬂuid culture with a
high density of bacteria, it is known that this substance can
cause aggregation of bacterial cells [20]. Additionally,
elevated ﬁbrinogen-binding capacity was found in the
two described strains, supporting the thesis of increased
FIG. 3. The different ST398 Staphylococcus aureus supernatants (SaSs) exhibit various cell lysis abilities. (a) Haemolysis of SaS in whole blood was
determined by the photometric measurement of free haemoglobin in human plasma (415 nm). The data are from six independent experiments
including six different blood donors. (b) Lysis of isolated human polymorphonuclear leukocytes (PMNs) by ST398 SaS was determined by mea-
surement of the proportion of propidium iodide (PI)-positive cells. For lysis determination, isolated PMNs (2.5 · 106/mL) were incubated with
ST398 SaS (25· concentrated SaS from overnight culture at a dilution of 1 : 25, representing the overnight culture concentration) for 10 min
(37C). Quantiﬁcation of lysis was performed by ﬂow cytometry analysis. The data are from six independent experiments including six different
blood donors. (c) Dot-blots after the PMN lysis assay with SaS from ST398b, ST398c, and ST398f, showing the gating parameter and special lysis
pattern. (d) The measured amount of a-haemolysin in ST398 SaS varied over a broad range. The relative amount of a-haemolysin from overnight
cultures was determined by ELISA. SaSs were pre-incubated with goat IgG (Jackson ImmunoResearch; Lot 84538) for 1 h to saturate possible
antibody-catching molecules. Each illustration includes six independent experiments. Error bars indicate ± standard deviation. (n = 6; ***p <0.001
as compared with porcine counterpart.). FSC, forward scatter; M, IMOM (negative control); OD, optical density.
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production of clumping factor A. With regard to the
identical result for the genes encoding the central adhesion
factors, the cell aggregation seems to be based on a higher
protein expression level.
The killing assay with and without exoprotein impact
impressively conﬁrms the special status of ST398b and, par-
ticularly, of ST398f. Under such in vitro conditions, in con-
trast to all tested strains, the secreted substances of ST398f
abrogate the killing by isolated PMNs in a highly signiﬁcant
manner. Although these data were obtained in vitro, they
might indicate an increase in the virulence of ST398f. The
reason for the higher survival rate in the absence of superna-
tants might be found in the modiﬁed adhesion abilities in
combination with the production and secretion of exopro-
teins only during the adhesion, phagocytosis and intracellular
killing process. In particular, greater host cell lysis in associa-
tion with upregulation of mRNAs encoding multiple toxins
and haemolysins, including a-haemolysin, have previously
been reported to account for differences in the killing of
hospital-acquired and community-acquired MRSA (see
below). Here, the exoproteins of ST398f in the concentra-
tion of the overnight culture were able to kill up to 100% of
isolated PMNs after 10 min of incubation. Cell lysis caused
by staphylococcal haemolysins is known to inﬂuence cytokine
release [21,22]. As expected, SaS-induced cytokine induction
in whole blood was directly linked to the varying lysing abili-
ties (Fig. S1).
As described previously, community-acquired MRSA
strains are able to avoid killing after phagocytosis by upregu-
lating a-haemolysin expression and secretion, and thereby
lysing the host cell [23]. This correlates with the large
amount of a-haemolysin detected in the supernatants of
ST398b and ST398f. Additionally, there are reports of
immune evasion by changing gene expression, including the
upregulation of other virulence factors [24,25]. ST398b
seems to represent an intermediate status characterized by
increased virulence towards humans, but seems to have less
signiﬁcance than ST398f.
The main source of the PMN and erythrocyte lysis
seems to be strong upregulation and secretion of haemoly-
sins and/or leukocidins. Despite the fact that PMNs seem
to be unaffected by a-haemolysin [26], in the absence of
Panton–Valentine leukocidin, the strongly enhanced a-
haemolysin expression of ST398b and ST398f indicates a
central role of a-haemolysin in the phenomena observed.
Current reports conﬁrm the major role of a-haemolysin in
S. aureus infections [27,28]. Further analysis will be neces-
sary for precise characterization of the lysis-inducing sub-
stances leading to the observed cell damage and
pathogenicity.
As we were not able to detect any differences between
the genes encoding the major virulence factors, including
haemolysins and adhesion proteins, it is probable that there
are variations in the regulatory mechanisms controlling the
expression of these virulence factors. Further genetic analysis
is necessary to elucidate the genetic modiﬁcations leading to
the observed massive increase in virulence. The intermediate
form ST398b might be an indicator of the possibility of a
step-by-step development, thus ruling out the thesis of a sin-
gle mutation.
In summary, we can postulate that the selected ST398
strain collection consists of two main groups, one lineage
of colonization strains of porcine and human origin, all char-
acterized by a similar phenotype, and one group consisting
of isolates from human colonization and abscesses, which
show a massive increase in pathogenic abilities. The abscess
as a symbol for a ‘frustrated’ immune response [29] corre-
lates with the strain phenotype representing the isolate
with the highest pathogenicity. The results demonstrate
that, besides genetic characterization, a combination with
phenotyping, including the human immune system, might be
a powerful tool with which to elucidate new aspects of
S. aureus.
In conclusion, because of the virulence pattern, we can
state that there is clear evidence of high heterogenicity in
the ST398 pool that cannot be detected with conventional
diagnostic methods. In the future, more studies at the
genetic and phenotype levels, including a higher number of
isolates, will be necessary to monitor ST398 in order to
develop new strategies against S. aureus, which is one of the
most adaptable and virulent pathogens in modern times.
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